Sanofi names new CFO and completes Ablynx acquisition

French pharma major Sanofi (Euronext: SAN) has appointed Jean-Baptiste Chasseloup de Chatillon as executive vice president, chief financial officer (CFO) and member of the executive committee, effective October 1, 2018.

He will join Sanofi on September 1 to ensure a smooth transition with Jérôme Contamine, who will retire on September 30, after more than nine years of distinguished service at Sanofi.

Mr Chasseloup de Chatillon most recently served as CFO and EVP for PSA Group. In this capacity he was also a member of the Managing Board and of the Executive Committee.